GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 1.03 -4.97 -10.6 -0.59 0.36   -3.02  
Changes by years, y/y, % -78% -585% +113% -94% -161%     -46.2%

GoodRx Holdings. Debt/EBITDA

GoodRx Holdings. Debt/EBITDA, changes, %

GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA -0.91 0.37 1.64 1.78 -3.02   -3.02
Changes by years, y/y, % +95% -161% -338% -465% +231%    
Changes by quarters, q/q, % +88% -141% +337% +9% -270%    

GoodRx Holdings. Debt/EBITDA

GoodRx Holdings. Debt/EBITDA, changes, y/y, %

GoodRx Holdings. Debt/EBITDA, changes, q/q, %